Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Aceso Life Science Group Limited ( (HK:0474) ).
Aceso Life Science Group Limited reported its audited consolidated results for the year ended March 31, 2025, showing a decrease in revenue from HK$228 million in 2024 to HK$195 million in 2025. The company faced significant financial challenges, including a substantial loss before taxation of HK$1,027 million, compared to HK$823 million the previous year. The results reflect a decline in gross profit and increased impairment losses, impacting the company’s financial stability and potentially affecting its market positioning.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited is a company incorporated in the Cayman Islands, operating in the life sciences industry. The company is focused on providing innovative solutions and services within this sector.
Average Trading Volume: 1,302,061
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.2M
See more data about 0474 stock on TipRanks’ Stock Analysis page.